Click any card to flip · 14 Step 1 high-yield concepts0 / 14 seen
Hirschsprung Disease
Classic presentation, pathophysiology, histologic finding, and key imaging?
Answer
Presentation: Neonate fails to pass meconium; abdominal distension Path: Neural crest cells fail to migrate → absent ganglia (both plexuses) in distal colon → tonic contraction Histo: Aganglionic segment (narrow) — dilated segment PROXIMAL is normal Imaging: Barium enema shows narrow distal + dilated proximal segment ("transition zone")
Achalasia
Pathophysiology, characteristic symptoms, imaging finding, and treatment options?
Answer
Path: Loss of inhibitory neurons (VIP/NO) at LES → LES fails to relax Sx: Progressive dysphagia (solids AND liquids), regurgitation, weight loss Imaging: "Bird-beak" on barium swallow; manometry shows absent LES relaxation Tx: Pneumatic dilation, Heller myotomy, or botulinum toxin (blocks ACh at LES)
What is first-pass metabolism, what types of drugs are most affected, and how can it be bypassed?
Answer
Definition: Drug absorbed from GI tract → portal vein → liver → hepatic metabolism BEFORE reaching systemic circulation → ↓bioavailability Most affected: Lipophilic drugs (morphine, nitroglycerin, propranolol, lidocaine) Bypass routes: Sublingual (nitroglycerin), IV, transdermal, rectal (partial bypass), inhalation
Myasthenia Gravis + GI
Why does myasthenia gravis cause dysphagia of the UPPER esophagus specifically?
Answer
Mechanism: MG destroys nicotinic ACh receptors at the NMJ → skeletal muscle weakness GI relevance: Only the upper esophagus and pharynx use skeletal muscle (voluntary swallowing initiation) Spared: Lower esophagus, stomach, intestines use smooth muscle (muscarinic signaling) → NOT affected by MG Contrast: Achalasia affects lower esophagus (smooth muscle/inhibitory neuron loss)
Cholera & GI Fluid Physiology
How does cholera cause such massive diarrhea, and why does ORS (oral rehydration solution) work?
Answer
Mechanism: Vibrio cholerae toxin → permanently activates adenylyl cyclase → ↑↑cAMP → massive Cl⁻ secretion → water follows osmotically → "rice-water" stools up to 20 L/day ORS works because: SGLT1 (Na⁺-glucose cotransporter) is NOT affected by cAMP → co-transporting Na⁺ + glucose still drives water absorption → bypasses the toxin's mechanism
Watershed Areas
What are the two GI watershed areas, why are they vulnerable, and what condition results from ischemia there?
Answer
Two watershed areas: 1. Splenic flexure (SMA/IMA border) — most vulnerable 2. Rectosigmoid junction (IMA/internal iliac border) Why vulnerable: End-arterial zones with minimal collateral flow Result of ischemia: Ischemic colitis — especially in elderly, post-aortic surgery, hypotension; presents as bloody diarrhea + left-lower quadrant pain
Step 1-Style MCQs: Select the best answer for each question. Your choice locks in immediately and the explanation reveals automatically. Green = correct, Red = incorrect.
Question 1 of 6 — Neurotransmitters / Achalasia
A 42-year-old woman presents with a 2-year history of progressive difficulty swallowing both solids and liquids, regurgitation of undigested food, and a 6 kg weight loss. Barium swallow shows smooth, tapered narrowing at the gastroesophageal junction with proximal esophageal dilation. Esophageal manometry demonstrates absent peristalsis and failure of the lower esophageal sphincter to relax after swallowing. Which neurotransmitter is most deficient at the LES in this condition?
AAcetylcholine
BSubstance P
CNitric oxide (NO)
DSerotonin (5-HT)
ENeuropeptide Y
C — Nitric oxide. Achalasia results from loss of inhibitory neurons (VIP + NO) at the LES. NO is the primary neurotransmitter responsible for LES relaxation during swallowing. Without NO, the LES remains tonically contracted. ACh/Substance P (choice A/B) are excitatory — their relative excess contributes to the failure to relax. Botulinum toxin (blocks ACh) is used therapeutically to partially restore balance.
Question 2 of 6 — Hirschsprung / Embryology
A 3-day-old male neonate has not passed meconium since birth. His abdomen is progressively distended and tympanitic. Rectal examination reveals explosive release of stool and gas when the finger is withdrawn. Rectal biopsy is obtained. Which of the following histologic findings is most expected in the affected aganglionic segment?
ANormal ganglion cells in the myenteric plexus with hypertrophied circular muscle
BAbsence of ganglion cells in both the myenteric and submucosal plexuses
CAbsence of ganglion cells only in the submucosal plexus with normal myenteric plexus
DIncreased numbers of ganglion cells due to neural hypertrophy proximal to the obstruction
EDilated, thin-walled bowel with normal ganglionic architecture
B — Absence of ganglion cells in BOTH plexuses. Hirschsprung disease is caused by failure of neural crest cells to migrate to the distal colon. Both the myenteric AND submucosal ganglia are absent in the affected segment. This results in tonic, unopposed smooth muscle contraction → functional obstruction. The biopsy is taken from the narrow, aganglionic segment (not the dilated proximal segment, which has normal ganglia and is dilated from stool accumulation above the obstruction).
Question 3 of 6 — Fluid Balance / Acid-Base
A 28-year-old woman with severe persistent vomiting (hyperemesis gravidarum) presents to the ED. ABG shows pH 7.55, pCO₂ 48 mmHg, HCO₃⁻ 40 mEq/L. Serum K⁺ is 2.8 mEq/L. Which of the following best explains the acid-base and electrolyte abnormalities?
ALoss of HCO₃⁻-rich fluid from the upper GI tract
BLoss of HCl from the stomach → relative increase in serum HCO₃⁻ + renal K⁺ wasting
CRespiratory alkalosis from hyperventilation due to nausea
DLoss of pancreatic bicarbonate causing metabolic acidosis
EAldosterone excess from volume depletion causing metabolic acidosis
B — HCl loss → metabolic alkalosis + hypokalemia. Vomiting causes loss of H⁺ and Cl⁻ from gastric secretions → serum HCO₃⁻ rises (metabolic alkalosis). Volume depletion → ↑aldosterone → Na⁺ reabsorption in exchange for K⁺ secretion → hypokalemia. To maintain electroneutrality, the kidney also excretes K⁺ and H⁺ ("paradoxical aciduria"). Key: pH 7.55 = alkalosis; pCO₂ 48 = compensatory retention of CO₂; elevated HCO₃⁻ confirms primary metabolic alkalosis.
Question 4 of 6 — Pharmacology / GI Hormones
A 55-year-old man presents with severe peptic ulcers in the duodenum and jejunum, watery diarrhea, and epigastric pain unresponsive to standard PPI therapy. Serum gastrin level is 1,800 pg/mL (normal <100). A secretin stimulation test causes a paradoxical RISE in gastrin. CT scan shows a 2 cm mass in the pancreatic head. Which of the following best describes the mechanism by which this patient's tumor causes diarrhea?
AVIP secretion → massive Cl⁻ secretion into the lumen
BDirect invasion of the intestinal mucosa by the tumor
DExcess serotonin from enterochromaffin cells stimulates secretory diarrhea
EHypersecretion of secretin → excessive pancreatic fluid output
C — Excess HCl → inactivates lipase + bile salts → steatorrhea. This is Zollinger-Ellison syndrome (gastrinoma). The elevated gastrin drives massive HCl secretion. The excess acid in the duodenum: (1) directly damages the mucosa → multiple ulcers; (2) inactivates pancreatic lipase (which needs pH 7–8) and precipitates bile salts → fat malabsorption → steatorrhea. The secretin stimulation test is diagnostic: normal physiology → secretin suppresses gastrin; ZES → paradoxical rise (gastrinoma cells lack normal feedback inhibition).
Question 5 of 6 — ENS / Opioids
A 68-year-old man with metastatic prostate cancer is started on IV morphine for pain control. Three days later he develops abdominal distension, absence of bowel sounds, and no bowel movements. Abdominal X-ray shows diffuse gaseous distension of the bowel without a transition point. His pain is currently well-controlled. Which drug would best treat his GI complication without affecting his analgesia?
ANaloxone IV
BAtropine
CMethylnaltrexone
DMetoclopramide
EOndansetron
C — Methylnaltrexone. This patient has opioid-induced paralytic ileus (μ-receptor activation on ENS neurons → ↓ACh release → ↓peristalsis). Methylnaltrexone is a peripherally-acting μ-opioid antagonist that does NOT cross the blood-brain barrier → reverses GI opioid effects without affecting CNS analgesia. Naloxone (A) would cross the BBB and reverse analgesia. Atropine (B) blocks muscarinic receptors → would worsen ileus. Metoclopramide (D) is a prokinetic but doesn't address the receptor mechanism directly. Ondansetron (E) is an antiemetic.
Question 6 of 6 — Blood Supply / Ischemia
A 72-year-old woman with a history of peripheral vascular disease undergoes elective repair of an infrarenal abdominal aortic aneurysm. On postoperative day 2 she develops crampy left-sided abdominal pain and bloody diarrhea. CT angiography shows patent aortic graft but no flow in the inferior mesenteric artery, which was sacrificed during the repair. Which segment of colon is MOST at risk for ischemia in this setting?
ACecum and ascending colon
BTransverse colon at its midpoint
CSplenic flexure and descending colon
DTerminal ileum
ERectum
C — Splenic flexure and descending colon. The splenic flexure is the watershed area between SMA and IMA territories — it has the most tenuous blood supply. When the IMA is sacrificed (common in aortic surgery), the descending colon and splenic flexure lose their primary supply. If collateral flow from SMA is inadequate (as in atherosclerotic disease), ischemic colitis develops at this watershed zone. The rectum (E) is protected by dual supply from IMA (superior rectal) + internal iliac (middle/inferior rectal arteries).
Ordering Drills: Arrange each sequence of steps in the correct physiologic or pathologic order. Drag items to reorder. Click "Check Order" to verify, or "Show Answer" to reveal the correct sequence.
Achalasia — From Neural Loss to Dysphagia
Trace the mechanism from loss of inhibitory neurons to the classic symptom of dysphagia.
Food bolus cannot pass into stomach
Proximal esophageal dilation develops
Loss of inhibitory neurons (VIP + NO) at LES
Progressive dysphagia to solids AND liquids
Tonic contraction of LES persists
LES fails to relax during swallowing
Loss of inhibitory neurons (VIP + NO) at LES
LES fails to relax during swallowing
Tonic contraction of LES persists
Food bolus cannot pass into stomach
Progressive dysphagia to solids AND liquids
Proximal esophageal dilation develops
Hirschsprung Disease — Pathogenesis Sequence
From embryologic failure to neonatal presentation.
Functional bowel obstruction develops
Absent ganglia in both myenteric and submucosal plexuses
Proximal segment dilates from stool accumulation
Neural crest cells fail to migrate to distal colon during embryogenesis
Aganglionic segment remains tonically contracted
Neonate fails to pass meconium within 48 hours
Neural crest cells fail to migrate to distal colon during embryogenesis
Absent ganglia in both myenteric and submucosal plexuses
Aganglionic segment remains tonically contracted
Functional bowel obstruction develops
Proximal segment dilates from stool accumulation
Neonate fails to pass meconium within 48 hours
Cholera Toxin — Mechanism of Secretory Diarrhea
How the toxin hijacks cAMP signaling to cause massive fluid secretion.
Massive increase in intracellular cAMP
B subunit binds GM1 ganglioside on intestinal epithelium
Water follows osmotically → rice-water stools
Vibrio cholerae produces AB toxin
CFTR channel opens → Cl⁻ secretion into lumen
A subunit ADP-ribosylates Gs alpha subunit
Permanent activation of adenylyl cyclase
Vibrio cholerae produces AB toxin
B subunit binds GM1 ganglioside on intestinal epithelium
A subunit ADP-ribosylates Gs alpha subunit
Permanent activation of adenylyl cyclase
Massive increase in intracellular cAMP
CFTR channel opens → Cl⁻ secretion into lumen
Water follows osmotically → rice-water stools
Parietal Cell Acid Secretion — Three Activation Pathways to H⁺/K⁺ ATPase
Order the steps from luminal stimulus to final acid output. Source: Bootcamp GI · Stomach
All three pathways converge on H⁺/K⁺ ATPase (proton pump) at apical membrane
Vagal stimulation releases ACh → binds M3 receptors on parietal cells (direct pathway)
All three pathways converge on H⁺/K⁺ ATPase (proton pump) at apical membrane
H⁺ secreted into gastric lumen in exchange for K⁺
PPIs irreversibly block this final common step; H2 blockers only block the histamine arm
Vignette MCQs: Clinical scenarios testing disease recognition and mechanisms. Select your best answer and the explanation appears automatically.
Vignette 1 of 3 — Carcinoid Syndrome
A 58-year-old man presents with episodic facial flushing, watery diarrhea, and audible wheezing. Physical exam reveals a holosystolic murmur at the left lower sternal border that increases with inspiration. CT shows multiple hepatic lesions and a 3-cm mass in the terminal ileum. Urine 5-HIAA is markedly elevated.
AGastrinoma
BVIPoma
CCarcinoid tumor with liver metastases
DPheochromocytoma
EMedullary thyroid carcinoma
C — Carcinoid tumor with liver metastases. Buzzwords: flushing, diarrhea, wheezing, right-sided heart murmur, hepatic lesions, urine 5-HIAA elevated. Carcinoid syndrome only manifests with liver mets because hepatic first-pass metabolism normally degrades serotonin. Right-sided heart disease (tricuspid regurgitation) is pathognomonic. The terminal ileum mass location is classic for midgut carcinoids.
Vignette 2 of 3 — ZES / Gastrinoma
A 50-year-old man has recurrent duodenal ulcers despite maximal PPI therapy. He also reports chronic watery diarrhea and 5 kg weight loss. Fasting serum gastrin is 1,500 pg/mL. A secretin stimulation test shows a paradoxical rise in gastrin levels. CT reveals a 2-cm pancreatic head mass.
AH. pylori infection
BGastrinoma
CVIPoma
DSomatostatinoma
ENSAID-induced gastropathy
B — Gastrinoma. Buzzwords: recurrent ulcers refractory to PPIs, fasting gastrin >1000, paradoxical rise with secretin, pancreatic mass. Gastrinoma triangle = duodenum + pancreatic head + cystic/common bile duct junction. The paradoxical secretin response is diagnostic: normal inhibition of gastrin does not occur in gastrinoma.
Vignette 3 of 3 — Opioid-Induced Ileus
A 65-year-old woman receiving IV morphine for post-surgical pain control develops progressive abdominal distension and absence of bowel sounds on day 3. Abdominal X-ray shows dilated loops of small and large bowel without a transition point. Her pain is well-controlled.
AMechanical small bowel obstruction
BOpioid-induced ileus
COgilvie syndrome
DToxic megacolon
EVolvulus
B — Opioid-induced ileus. Buzzwords: morphine, no bowel sounds, no transition point, pain well-controlled. μ-opioid receptors on ENS neurons → ↓ACh release → ↓peristalsis. Treat with methylnaltrexone (peripheral μ-antagonist, does NOT cross BBB) to preserve analgesia while restoring GI motility.
Vignette 4 of 4 — VIPoma / WDHA Syndrome
A 45-year-old woman presents with 3 weeks of profuse, watery diarrhea (up to 3 liters/day) unresponsive to fasting. Labs reveal K⁺ 2.4 mEq/L and achlorhydria on gastric pH testing. She has lost 8 kg. CT abdomen shows a 4-cm mass in the pancreatic tail. Serum VIP levels are markedly elevated.
AGastrinoma
BCarcinoid tumor
CVIPoma
DGlucagonoma
ESomatostatinoma
C — VIPoma. Buzzwords: watery diarrhea, hypokalemia, achlorhydria, pancreatic mass, unresponsive to fasting. This is the WDHA syndrome (Verner-Morrison). VIP → ↑cAMP in intestinal epithelium → massive Cl⁻/H₂O secretion ("pancreatic cholera"). Key distinguisher: the diarrhea is SECRETORY (persists with fasting, unlike osmotic). Non-α, non-β, non-δ islet cell tumor. Treatment: octreotide (somatostatin analog) + surgical resection.
Step 1 Traps: Common false statements that appear plausible but are incorrect. Choose the correct answer to reveal the trap explanation.
Trap 1 of 5
In Hirschsprung disease, the DILATED segment of colon is the abnormal aganglionic portion.
This is a classic exam trap. The NARROW segment is aganglionic (abnormal) — it is tonically contracted because there are no inhibitory ganglia. The DILATED segment proximal to it is actually NORMAL — it has intact ganglia and is simply distended from stool accumulation above the obstruction. Biopsy must be taken from the narrow segment to confirm diagnosis.
Trap 2 of 5
Carcinoid syndrome can occur with a small intestinal carcinoid tumor even without liver metastases.
Serotonin produced by intestinal carcinoid tumors drains via portal circulation into the liver, where it is degraded by first-pass metabolism. Carcinoid syndrome (flushing, diarrhea, bronchospasm, right heart disease) only occurs when liver metastases secrete serotonin directly into the systemic circulation, bypassing hepatic degradation. Exception: bronchial carcinoids can cause syndrome without liver mets (drain directly into systemic veins).
Trap 3 of 5
Naloxone is the preferred treatment for opioid-induced constipation because it directly reverses μ-receptor activation in the GI tract.
Naloxone crosses the BBB and reverses BOTH peripheral (GI) and central (analgesia) effects — it would reverse pain control. Methylnaltrexone is preferred because it blocks μ-receptors peripherally but does NOT cross the BBB, preserving CNS analgesia while treating GI symptoms.
Trap 4 of 5
PPIs are more potent than H2 blockers because they block the histamine receptor more effectively.
PPIs and H2 blockers target completely different molecules. H2 blockers block the histamine H2 receptor (one of three stimulatory pathways to parietal cells). PPIs irreversibly inhibit the H⁺/K⁺ ATPase proton pump — the FINAL COMMON PATHWAY of all acid secretion, regardless of stimulus (histamine, ACh, gastrin). This is why PPIs are more potent: they block the downstream pump, not an upstream receptor.
Trap 5 of 5
In achalasia, the lower esophageal sphincter is structurally damaged and cannot contract.
In achalasia, the LES can contract perfectly well — the problem is it cannot RELAX. Loss of inhibitory neurons (VIP/NO) removes the relaxation signal. The excitatory neurons (ACh/Substance P) are still intact, so the LES remains tonically contracted. That is why botulinum toxin (which blocks ACh release) is a treatment — it reduces the excitatory tone to partially compensate for the missing inhibitory signal.
Trap 6 of 7
Atropine can block vagal stimulation of gastrin secretion from G cells because the vagus nerve uses acetylcholine.
Vagal stimulation of G cells does NOT use ACh directly — it uses gastrin-releasing peptide (GRP/bombesin) as the neurotransmitter. Therefore atropine (muscarinic antagonist) does NOT inhibit gastrin release. This is a tested distinction from Bootcamp: vagal stimulation of parietal cells uses ACh (blocked by atropine), but vagal stimulation of G cells uses GRP (NOT blocked by atropine). Students who assume "vagus = ACh everywhere" get trapped.
Trap 7 of 7
H2 blockers suppress both meal-stimulated and nocturnal gastric acid secretion equally well.
H2 blockers are effective for NOCTURNAL acid suppression but have only a modest effect on MEAL-STIMULATED acid secretion. During meals, parietal cells receive stimulation via three pathways (ACh-M3, gastrin-CCK-B, histamine-H2). Blocking only the histamine arm still allows acid secretion via the ACh and gastrin pathways. PPIs are more potent because they block the H⁺/K⁺ ATPase — the FINAL COMMON PATHWAY downstream of all three stimuli. This is why PPIs suppress both nocturnal AND meal-stimulated acid.
Reference Tables: Quick-lookup tables for GI secretory tumors and pharmacology. Print-friendly format.
GI Secretory Tumors — Quick Comparison
Tumor
Hormone
Key Lab
Classic Presentation
Diarrhea Mechanism
Gastrinoma
Gastrin
Fasting gastrin >1000, secretin stim test
Multiple refractory ulcers
Acid inactivates lipase/bile salts → steatorrhea
VIPoma
VIP
Elevated serum VIP
WDHA syndrome
↑cAMP → Cl⁻ secretion → watery
Carcinoid
Serotonin (5-HT)
Urine 5-HIAA elevated
Flushing, wheezing, right heart disease
5-HT stimulates secretion + motility
GI Pharmacology — Drug Targets and Mechanisms
Drug Class
Target
Mechanism
Clinical Use
Key Side Effect
PPIs
H⁺/K⁺ ATPase
Irreversible pump inhibition
GERD, PUD, ZES
Long-term: ↓Mg²⁺, C. diff risk, bone fractures
H2 Blockers
Histamine H2 receptor
↓cAMP in parietal cells
GERD, PUD (less severe)
Cimetidine: anti-androgen effects, CYP inhibition
Ondansetron
5-HT3 receptor
Blocks serotonin-mediated emesis
Chemo/post-op nausea
QT prolongation
Metoclopramide
D2 + 5-HT4
D2 antagonist + 5-HT4 agonist → prokinetic
Gastroparesis, GERD
Tardive dyskinesia (crosses BBB)
Methylnaltrexone
Peripheral μ-opioid
Blocks GI μ-receptors, NOT CNS
Opioid-induced constipation
Does NOT reverse analgesia
Parietal Cell Acid Secretion — Three Stimulatory Pathways
Pathway
Stimulus
Receptor
Second Messenger
Drug That Blocks
Histamine (ECL cells)
Gastrin → ECL → histamine release
H2
cAMP ↑
H2 blockers (ranitidine, famotidine)
ACh (vagus nerve)
Vagal stimulation
M3
IP3/Ca²⁺ ↑
Atropine (muscarinic antagonist)
Gastrin (G cells)
Amino acids, distension, vagal GRP
CCK-B
IP3/Ca²⁺ ↑
No specific blocker (somatostatin inhibits release)
Final common pathway: All three converge on H⁺/K⁺ ATPase → PPIs block this step regardless of stimulus
High-Yield Testing Notes: Key patterns to recognize on exams. Badges indicate trap concepts, buzzword clusters, and testing-focused insights.
TESTING Hirschsprung vs. Achalasia — The Neural Crest Distinction
Both test ENS dysfunction but from different angles. Hirschsprung = failure of neural crest MIGRATION (embryology focus). Achalasia = loss of inhibitory NEURONS at LES (neurotransmitter focus). Step 1 loves pairing these because the underlying pathology (absent inhibitory innervation) is conceptually similar, but the location, age of onset, and management differ completely.
TRAP The Dilated vs. Narrow Segment Trap
The #1 exam trap for Hirschsprung: students assume the dilated segment is abnormal. Wrong — the NARROW segment lacks ganglia (aganglionic, abnormal). The dilated segment is NORMAL bowel that has expanded from backed-up stool. Biopsy of the narrow segment shows absent ganglion cells. This is tested repeatedly in different formats.
BUZZWORD Carcinoid Syndrome Buzzword Cluster
When a vignette includes ANY combination of: flushing + diarrhea + wheezing + right-sided heart murmur + hepatic masses → carcinoid with liver mets. Confirmatory test = elevated urine 5-HIAA. The liver mets detail is key — without it, serotonin is degraded by first-pass hepatic metabolism and the syndrome does not manifest.
TESTING Secretory Tumor Differentiation
Step 1 differentiates gastrinoma, VIPoma, and carcinoid by their clinical fingerprint. Gastrinoma: refractory ulcers + paradoxical secretin test. VIPoma: WDHA (watery diarrhea, hypokalemia, achlorhydria). Carcinoid: flushing + right-sided heart disease + liver mets. Each has a unique lab marker (gastrin, VIP, 5-HIAA). They often appear as "which tumor" questions with a clinical vignette.
TRAP Naloxone vs. Methylnaltrexone — BBB Trap
Exam trap: a patient on morphine with constipation — which drug treats it without reversing analgesia? Naloxone crosses the BBB → reverses everything (pain control lost). Methylnaltrexone does NOT cross the BBB → blocks peripheral μ-receptors only → restores GI motility while preserving CNS analgesia. This is tested as a pharmacology application question, not pure recall.
BUZZWORD Pellagra from Carcinoid — Tryptophan Diversion
Carcinoid tumors divert tryptophan toward serotonin synthesis, depleting the pool available for niacin (vitamin B3) production. Result: pellagra (the 3 Ds — diarrhea, dermatitis, dementia). Buzzword cluster on Step 1: carcinoid + pellagra-like skin changes + diarrhea + psychiatric symptoms. The connection is that serotonin overproduction starves the niacin pathway. Serum marker: chromogranin A (neuroendocrine tumors, APUD cells). Right-sided heart valvular disease occurs because lungs contain MAO that metabolizes serotonin before it reaches the left heart.
Three independent pathways stimulate acid secretion: histamine (H2 → cAMP), ACh (M3 → IP3/Ca²⁺), and gastrin (CCK-B → IP3/Ca²⁺). H2 blockers only block one arm, which is why they mainly suppress nocturnal acid (histamine-dominant). PPIs block the H⁺/K⁺ ATPase — the final common pathway where all three signals converge — making them effective regardless of the stimulus. Step 1 tests this as: "Why is a PPI more effective than an H2 blocker?" or presents a patient failing H2 blocker therapy and asks for the next pharmacologic step.
Clinical Correlates: Review key disease profiles and clinical connections. Click "Show" to reveal comparison details.
ENS Pathology
Achalasia vs. Hirschsprung — Key Distinguishing Features
Both involve loss of inhibitory ENS neurons, but the affected location differs completely.
Achalasia: Loss of VIP/NO neurons at the LES → LES fails to relax → progressive dysphagia solids AND liquids, regurgitation, bird-beak on barium swallow. Adults. Possible autoimmune etiology or Chagas disease (Trypanosoma cruzi).
Hirschsprung: Absent ganglia (both plexuses) in distal colon → tonic contraction → functional obstruction. Neonates. Failure of neural crest migration. Presents as failure to pass meconium.
Feature
Achalasia
Hirschsprung
Location
LES / esophagus
Distal colon (always to anus)
NT lost
VIP + NO
Both plexuses absent
Presentation
Dysphagia, regurgitation
No meconium, abdominal distension
Treatment
Pneumatic dilation / Heller myotomy / Botox
Surgical resection of aganglionic segment
GI Hormone Tumors
Gastrinoma vs. VIPoma vs. Carcinoid — The "Secretory Tumor" Triad
Three Step 1 tumors defined by their hormone product and GI consequences: